Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma

• Published in: Annals of oncology Vol. 18; no. 11; pp. 1906 - 1907
• Main Authors: Mego, M., Reckova, M., Obertova, J., Sycova-Mila, Z., Brozmanova, K., Mardiak, J.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.11.2007; Oxford Publishing Limited (England)
• Subjects: Aged; Atrial Fibrillation - chemically induced; Atrial Fibrillation - physiopathology; Benzenesulfonates - adverse effects; Benzenesulfonates - therapeutic use; Carcinoma, Renal Cell - drug therapy; Carcinoma, Renal Cell - pathology; Carcinoma, Renal Cell - secondary; Cardiovascular Diseases - chemically induced; Cardiovascular Diseases - physiopathology; Chest Pain - chemically induced; Chest Pain - physiopathology; Drug Interactions; Follow-Up Studies; Humans; Indoles - adverse effects; Indoles - therapeutic use; Kidney Neoplasms - drug therapy; Kidney Neoplasms - pathology; Middle Aged; Myocardial Ischemia - chemically induced; Myocardial Ischemia - physiopathology; Neoplasm Invasiveness - pathology; Neoplasm Staging; Niacinamide - analogs & derivatives; Phenylurea Compounds; Pyridines - adverse effects; Pyridines - therapeutic use; Pyrroles - adverse effects; Pyrroles - therapeutic use; Risk Assessment; Sampling Studies; Severity of Illness Index; Sorafenib; Sunitinib
• ISSN: 0923-7534; 1569-8041
• DOI: 10.1093/annonc/mdm489